Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ROSCAN

Financiado

Cerrado

The role of ROS RNS during inflammation associated and sporadic carcinogenesis

"A link between inflammation and cancer has been suspected over a long period of time and in recent years genetic evidence supporting such notion could be obtained. Several signaling pathways, such as NF-κB and STAT3, could be ide... ver más

30/09/2016

Georg-Speyer-Haus

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2016-09-30 No tenemos la información de la convocatoria

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

Georg-Speyer-Haus

0.00€ | Lider

TUM-MED

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

PID2021-127199NB-I00 MECANISMO DE DAÑO EN EL ADN POR EXCITACION QUIMICA 139K€ Cerrado

BFU2016-80006-P FUNCION DE LAS PEROXIRREDOXINAS EN LA HOMEOSTASIS CELULAR CO... 157K€ Cerrado

PEROXIREDOXIN-CLOCK A new intracellular metabolic timer mechanism to induce cell... 231K€ Cerrado

BFU2010-15049 ESTRES OXIDATIVO, APOPTOSIS Y CANCER. IMPLICACIONES DE LA ME... 121K€ Cerrado

SAF2009-08493 PAPEL DEL RECEPTOR NUCLEAR FXR EN LA DEFENSA CONTRA EL ESTRE... 36K€ Cerrado

REDOXCYCLE The molecular interface between cell cycle and redox regulat... 1M€ Cerrado

Líder del proyecto

CHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto "A link between inflammation and cancer has been suspected over a long period of time and in recent years genetic evidence supporting such notion could be obtained. Several signaling pathways, such as NF-κB and STAT3, could be identified by our group as well as other groups to play important roles during tumor promotion and progression. Chronic inflammation leads to the formation of reactive oxygen and nitrogen species, which are known to cause DNA damage and inactivation of DNA repair mechanisms, thereby presumably inducing tumor-initiating mutations. On the other hand, oxidative stress has been documented to trigger apoptosis and cellular senescence. However, in vivo evidence demonstrating the consequences of increased oxidative stress on tumor development in a distinct genetic model is lacking. Selenoproteins of the glutathione peroxidase and thioredoxin reductase family are important anti-oxidant scavenger systems. Using cell type specific inactivation (epithelial cells an myeloid cells) of several of these family members in various well established and relevant models of inflammation-associated and sporadic colon tumorigenesis we will directly examine the role of these anti-oxidant systems. These models will allow us to genetically determine the outcome of increased lipid peroxidation and accumulation of reactive oxygen species in each cell type and to address whether cancer development is supported or inhibited under such conditions and will help to identify which phase of tumor development is affected. Furthermore, we expect to obtain results that will determine whether increased levels of ROS/RNS found during chronic inflammation are capable of initiating tumorigenesis. Our proposed experiments are supposed to provide fundamental insight into the molecular changes in the tumor microenvironment, which will ultimately help to identify novel strategies to prevent and treat colorectal cancer."

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores